Evidence map›Paper›PMID 42918975›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2027

Introduction to Allergy Modeling Across Species with Ethical and Regulatory Considerations.

José de la Fuente, Alejandro Cabezas-Cruz

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2027. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

José de la FuenteSaBio, Instituto de Investigación en Recursos Cinegéticos, IREC (CSIC, UCLM,  JCCM), Ronda de Toledo 12, Ciudad Real, 13005, Spain. jose_delafuente@yahoo.com.ORCID http://orcid.org/0000-0001-7383-9649
Alejandro Cabezas-CruzUMR BIPAR (INRAE, Anses  EnvA), 22 Rue Pierre et Marie Curie, Maisons-Alfort, 94700, France. alejandro.cabezas@vet-alfort.fr.ORCID http://orcid.org/0000-0002-8660-730X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allergic diseases affect the health and quality of life of humans and domestic animals. The prevalence of allergic diseases is increasing and likely associated with changes in climate and lifestyle conditions with decreased exposure to beneficial microorganisms. Animal models include multiple species (e.g., mice, rats, zebrafish, guinea pigs, dogs, cats, sheep, swine, monkeys) that are essential to study the immunological mechanisms of allergic diseases and to evaluate new therapies that can be beneficial for both humans and animals. The animal models contribute to overcoming ethical limitations in human research and have been scientifically validated with the required approval of ethical committees for animal experimentation. The animal models guide allergy modeling with different methods and translational protocols disclosed in the Methods in Molecular Biology book, "Allergic Disease Models: Methods and Translational Protocols".

Indexed as

Disease Models, AnimalHypersensitivityAnimalsCatsDogsGuinea PigsHumansMiceRatsAllergyAlpha-Gal SyndromeArtificial IntelligenceCitizen scienceData integrationDiseaseMicrobiotaModel

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.